Transcription factor dose links development to disease

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Simmons et al report that low expression levels of the transcription factor Pax-5 in B-lineage progenitors results in the formation of highly proliferative B220+CD11b+ cells expressing both lymphoid and myeloid genes much in resemblance to cells generated in acute lymphoblastic leukemia (ALL)-like bi-phenotypic acute leukemia (BAL). 1 In contrast, high expression levels of Pax-5 in the progenitors result in expression of CD19 and apparently stable B-lineage commitment, suggesting a critical role for Pax-5 dose in both normal B-cell development and in the generation of leukemia. (Figure Presented).

Cite

CITATION STYLE

APA

Sigvardsson, M. (2012, November 1). Transcription factor dose links development to disease. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-09-455113

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free